검색어 : 통합검색[930.1]
총 2,604건 중 1,000건 출력
, 2/100 페이지
-
11
- 930. Fluorescent whitening agents. Part I. 1,3-Diaryl-2-pyrazolines
- Chase, B. H.; Evans, J. M.; ; (Journal of the Chemical Society (Resumed), v.1964, 1964, pp.4825-4831)
-
12
- Development of a selective S1P<sub>1</sub> receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis
- Jin, J.; Hu, J.; Zhou, W.; Wang, X.; Xiao, Q.; Xue, N.; Yin, D.; Chen, X.; ; (Biochemical pharmacology, v.90, 2014, pp.50-61)
-
13
- Heterodyne frequency measurements on N<SUB>2</SUB>O near 930 cm<SUP>−1</SUP>
- Maki, A.G.; ; (Journal of molecular spectroscopy, v.138, 1989, pp.84-88)
-
14
- MAML1 mediates MEF2C degradation independent of ubiquitination (930.5)
- Zein, Ivan; White, Brandon; Biological science San Jose State University San Jose CA United States; Biological science San Jose State University San Jose CA United States; (The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, v.28, 2014, pp.930.5)
-
15
- Trafton v. Sunbury Primary Care, P.A., 1225(a)(1), 930
- ; ; (Mental and physical disability law reporter, v.34, 2010, pp.433)
-
16
- Delgado v. Certified Grocers Midwest, 1225(b)(1), 1225(b)(2), 1225(a)(1), 930
- ; ; (Mental and physical disability law reporter, v.31, 2007, pp.749)
-
17
- Martin v. Discount Smoke Shop, Inc., 1225(b)(1), 1225(a)(1), 930, 2002(a)
- ; ; (Mental and physical disability law reporter, v.30, 2006, pp.772)
-
18
- Domurat v. Ciba Specialty Chems. Corp., 904(c)(3), 904(c)(1), 930
- ; ; (Mental and physical disability law reporter, v.26, 2002, pp.838)
-
19
- £2bn shortfall expected as deficit sinks to £930m in Q1
- ; ; (The Health service journal, v.6463, 2015, pp.4-4)
-
20
- Germano v. International Profit Ass'n, Inc., 1225(d), 1225(a)(1), 930
- ; ; (Mental and physical disability law reporter, v.32, 2008, pp.120)
QUICK MENU
